{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:27:05Z","timestamp":1778718425528,"version":"3.51.4"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1097\/md.0000000000000462","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T11:22:52Z","timestamp":1423740172000},"page":"e462","source":"Crossref","is-referenced-by-count":65,"title":["Cancer Risk in HBV Patients With Statin and Metformin Use"],"prefix":"10.1097","volume":"94","author":[{"given":"Chang-I.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Feng","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ann","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shing-Hwa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Chia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaulang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Miser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210226","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ije\/dyh339","article-title":"Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study.","volume":"34","author":"Chen","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R2-5-20210226","first-page":"10","article-title":"The statins as anticancer agents.","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R3-5-20210226","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.leu.2402476","article-title":"HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.","volume":"16","author":"Wong","year":"2002","journal-title":"Leukemia"},{"key":"R4-5-20210226","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1073\/pnas.122228799","article-title":"3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPasep21 signaling pathway: implications for diabetic nephropathy.","volume":"99","author":"Danesh","year":"2002","journal-title":"Proc Nat Acad Sci U S A"},{"key":"R5-5-20210226","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/01.CIR.0000089086.48617.2B","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.","volume":"23","author":"Blanco-Colio","year":"2003","journal-title":"Circulation"},{"key":"R6-5-20210226","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscl Thrombo Vascul Biol"},{"key":"R7-5-20210226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/24.3.453","article-title":"Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.","volume":"24","author":"Shibata","year":"2003","journal-title":"Carcinogenesis"},{"key":"R8-5-20210226","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.96.14.7797","article-title":"Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.","volume":"96","author":"Rao","year":"1999","journal-title":"Proc Nat Acad Sci U S A"},{"key":"R9-5-20210226","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/hep.1840200631","article-title":"Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells.","volume":"20","author":"Mallat","year":"1994","journal-title":"Hepatology"},{"key":"R10-5-20210226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/CCO.0b013e32834d8155","article-title":"Metformin and cancer therapy.","volume":"24","author":"Bost","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"R11-5-20210226","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer.","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J"},{"key":"R12-5-20210226","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"R13-5-20210226","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","article-title":"Obesity and cancer risk: the role of the insulin-IGF axis.","volume":"17","author":"Renehan","year":"2006","journal-title":"Trends Endocrinol Metabol"},{"key":"R14-5-20210226","doi-asserted-by":"crossref","first-page":"e11394","DOI":"10.1371\/journal.pone.0011394","article-title":"Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.","volume":"5","author":"Hess","year":"2010","journal-title":"PLoS One"},{"key":"R15-5-20210226","first-page":"604","article-title":"Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.","volume":"57","author":"Gray-Bablin","year":"1997","journal-title":"Cancer Res"},{"key":"R16-5-20210226","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.onc.1202322","article-title":"Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.","volume":"17","author":"Rao","year":"1998","journal-title":"Oncogene"},{"key":"R17-5-20210226","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-07-2489","article-title":"Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.","volume":"68","author":"Furuta","year":"2008","journal-title":"Cancer Res"},{"key":"R18-5-20210226","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/jnci\/djr291","article-title":"Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.","volume":"103","author":"Ahern","year":"2011","journal-title":"J Nat Cancer Inst"},{"key":"R19-5-20210226","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/gut.2009.190900","article-title":"Effect of statin therapy on colorectal cancer.","volume":"59","author":"Bardou","year":"2010","journal-title":"Gut"},{"key":"R20-5-20210226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis.","volume":"295","author":"Dale","year":"2006","journal-title":"JAMA"},{"key":"R21-5-20210226","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1200\/JCO.2007.10.8936","article-title":"Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.","volume":"25","author":"Bonovas","year":"2007","journal-title":"J Clin Oncol"},{"key":"R22-5-20210226","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"R23-5-20210226","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prevent Res"},{"key":"R24-5-20210226","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"key":"R25-5-20210226","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/dc11-1829","article-title":"Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients.","volume":"35","author":"Lehman","year":"2012","journal-title":"Diabetes Care"},{"key":"R26-5-20210226","doi-asserted-by":"crossref","first-page":"S800","DOI":"10.1016\/j.ijrobp.2014.05.2311","article-title":"Combination of metformin and statins significantly enhanced the local radio therapeutic effect and attenuated the lung metastasis of lewis lung carcinoma (LLC) animal model.","volume":"90","author":"Wu","year":"2014","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"R27-5-20210226","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"R28-5-20210226","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients.","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"R29-5-20210226","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3748\/wjg.15.2506","article-title":"Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.","volume":"15","author":"Donadon","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R30-5-20210226","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"key":"R31-5-20210226","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.24982","article-title":"Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.","volume":"116","author":"Hassan","year":"2010","journal-title":"Cancer"},{"key":"R32-5-20210226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with antidiabetic therapy: a population-based cohort study.","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R33-5-20210226","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell cycle"},{"key":"R34-5-20210226","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cc.8.1.7499","article-title":"The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.","volume":"8","author":"Vazquez-Martin","year":"2009","journal-title":"Cell cycle"},{"key":"R35-5-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12094-009-0384-0","article-title":"Menendez JA. mTOR inhibitors and the antidiabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb).","volume":"11","author":"Vazquez-Martin","year":"2009","journal-title":"Clin Translational Oncol"},{"key":"R36-5-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12094-011-0669-y","article-title":"Metformin: a new option in cancer treatment.","volume":"13","author":"Belda-Iniesta","year":"2011","journal-title":"Clin Translational Oncol"},{"key":"R37-5-20210226","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1074\/jbc.M309773200","article-title":"Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398.","volume":"279","author":"Browne","year":"2004","journal-title":"J Biol Chemistry"},{"key":"R38-5-20210226","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth.","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"key":"R39-5-20210226","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival.","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"R40-5-20210226","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint.","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"key":"R41-5-20210226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","article-title":"Diabetes mellitus and breast cancer.","volume":"6","author":"Wolf","year":"2005","journal-title":"Lancet Oncol"},{"key":"R42-5-20210226","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies.","volume":"92","author":"Huxley","year":"2005","journal-title":"Br J Cancer"},{"key":"R43-5-20210226","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: a meta-analysis.","volume":"97","author":"Larsson","year":"2005","journal-title":"J Nat Cancer Inst"},{"key":"R44-5-20210226","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis.","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"R45-5-20210226","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13813450902878054","article-title":"Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.","volume":"115","author":"Becker","year":"2009","journal-title":"Arc Physiol Biochem"},{"key":"R46-5-20210226","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response.","volume":"74","author":"Schroder","year":"2005","journal-title":"Ann Rev Biochem"},{"key":"R47-5-20210226","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/0008-5472.CAN-08-2689","article-title":"Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation.","volume":"69","author":"Saito","year":"2009","journal-title":"Cancer Res"},{"key":"R48-5-20210226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000225596","article-title":"Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances.","volume":"39","author":"Dilman","year":"1982","journal-title":"Oncology"},{"key":"R49-5-20210226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism.","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"R50-5-20210226","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"R51-5-20210226","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-010-0924-x","article-title":"The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.","volume":"126","author":"Vazquez-Martin","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R52-5-20210226","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.4161\/cc.9.18.13131","article-title":"Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.","volume":"9","author":"Vazquez-Martin","year":"2010","journal-title":"Cell Cycle"},{"key":"R53-5-20210226","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"R54-5-20210226","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.4161\/cc.9.22.14048","article-title":"Metformin against TGFbeta-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.","volume":"9","author":"Cufi","year":"2010","journal-title":"Cell Cycle"},{"key":"R55-5-20210226","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2011.36.0917","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.","volume":"30","author":"Tsan","year":"2012","journal-title":"J Clin Oncol"},{"key":"R56-5-20210226","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.21232","article-title":"Different anti-HCV profiles of statins and their potential for combination therapy with interferon.","volume":"44","author":"Ikeda","year":"2006","journal-title":"Hepatology"},{"key":"R57-5-20210226","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"key":"R58-5-20210226","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","article-title":"Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.","volume":"166","author":"Inoue","year":"2006","journal-title":"Arc Internal Med"},{"key":"R59-5-20210226","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hep.21208","article-title":"Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection.","volume":"43","author":"Lai","year":"2006","journal-title":"Hepatology"},{"key":"R60-5-20210226","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1872-034X.2007.00077.x","article-title":"Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report.","volume":"37","author":"Torisu","year":"2007","journal-title":"Hepatol Res"},{"key":"R61-5-20210226","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1023\/A:1014715327729","article-title":"Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.","volume":"47","author":"Tazawa","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R62-5-20210226","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejca.2010.07.010","article-title":"The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.","volume":"47","author":"Ben","year":"2011","journal-title":"Eur J Cancer"},{"key":"R63-5-20210226","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.","volume":"4","author":"El-Serag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R64-5-20210226","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10654-009-9338-7","article-title":"Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort.","volume":"24","author":"Heidemann","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"R65-5-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwm333","article-title":"Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.","volume":"167","author":"Saltzman","year":"2008","journal-title":"Am J Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:39Z","timestamp":1620960039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201502020-00005"}},"subtitle":["A Population-Based Cohort Study"],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000462","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}